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Abstract: Infectious laryngotracheitis virus (ILTV) is a promising vaccine vector due to its 
heterologous gene accommodation capabilities, low pathogenicity, and potential to induce cellular 
and humoral arms of immunity. Owing to these characteristics, different gene-deletion versions of 
ILTVs have been successfully deployed as a vector platform for the development of recombinant 
vaccines against multiple avian viruses using conventional recombination methods, which are 
tedious, time-demanding, and error-prone. Here, we applied a versatile, and customisable 
clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 accompanied with Cre–
Lox system to simultaneously delete virulence factors and to insert foreign genes in the ILTV 
genome. Using this pipeline, we successfully deleted thymidine kinase (TK) and unique short 4 
(US4) genes and inserted fusion (F) gene of the Newcastle disease virus without adversely 
affecting ILTV replication and expression of the F protein. Taken together, the proposed approach 
offers novel tools to attenuate (by deletion of virulence factor) and to generate multivalent (by 
insertion of heterologous genes) vaccine vectors to protect chickens against pathogens of poultry 
and public health importance. 
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1. Introduction 
Infectious laryngotracheitis virus (ILTV), also known as Gallid herpesvirus 1, causes 
economically devastating respiratory disease in chickens around the globe. ILTV is a prototypic 
member of the genus Iltovirus of the family Herpesviridae and primarily replicates in the epithelial 
cells of the upper respiratory tract, including conjunctiva, trachea, and larynx [1], leading to the 
characteristics gasping, coughing, expectoration of bloody mucus, and conjunctivitis. Generally, 
ILTV remains latent in sensory neurons without any apparent clinical signs; however, due to 
various stresses, occasional reactivation can lead to virus shedding [2]. 
Similar to mammalian herpesviruses, the genome of ILTV carries a number of unique long 
(UL) and unique short (US) sequences. However, the genomic organisation and genetic distances 
are distinctive for ILTV [3,4]. Compared to other herpesviruses, iltovirus-specific genes include 
relocation of UL47 gene from UL to US regions, the inversion of a conserved gene cluster within the 
UL region (i.e., UL22 to UL44) [5–7]. The ILTV carries 12 glycoproteins, and several of these proteins 
(e.g., gB, gC, gG, gJ, gM, and gN) have been functionally characterised. On the other hand, several 
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glycoproteins (gG, gJ, gM, and gN) are not crucial for virus replication, and deletion of gG and gJ 
leads to the attenuation of ILTV in chickens [8,9]. The UL23 (encoding for thymidine kinase, TK) is 
one of the well-characterised virulence factors in herpesviruses, and deletion of TK gene attenuates 
the pathogenicity of ILTV, while maintaining the immunogenicity against challenged virus [10]. 
The US4 (gG) is a non-structural protein (not incorporated into mature virus particles) and is 
secreted from infected cells only [11,12]. Based on studies on multiple herpesviruses, it has been 
proposed that US4 modulates the host immune response by binding to chemokines [13], and 
gG-negative bovine herpesvirus-1 (BHV-1) mutants were attenuated in cattle [14]. Taken together, 
knocking out TK and US4 from ILTV genome could propose a stable vaccine vector.  
Owing to low mortality and moderate impacts on weight gain and egg production, the live 
attenuated strains of ILTV are widely exploited as a vector to develop recombinant and multivalent 
vaccines [15–17]. Moreover, due to the replication in the upper respiratory tract, the vaccine can 
successfully be deployed for mass application through eye-drops, aerosol, or drinking water [18]. 
The ILTV vector proposes additional advantages through potent induction of both cellular and 
humoral immune responses, and enabling differentiation between infected and vaccinated animals 
(DIVA) [18]. In both of these applications, conventionally attenuated live-virus vaccines are applied, 
which can pose significant residual virulence or can potentially revert into virulent phenotypes 
after several passages in animals [19–21]. To propose a safer vectored vaccine, efforts have been 
made to delete virulence genes from the ILTV genome, either by conventional homologous 
recombination in virus-infected cells or through recombineering techniques on full-length genomes 
[18]. However, the generation of recombinant ILTV using these methods is time-consuming, 
requiring the construction of transfer vectors and several rounds of plaque purifications to obtain 
the recombinant vaccine candidate. These shortcomings warrant application of next generation 
genome-editing approaches for the generation of safer, stable, and efficient vaccine vectors to be 
deployed in avian disease (e.g., Newcastle disease virus (NDV), avian influenza, and infectious 
bronchitis virus) control programmes.  
The recent discovery of CRISPR (clustered regularly interspaced short palindromic repeat)–
Cas9 system has revolutionised genome editing and is opening new avenues of genetic 
manipulation. The functional components of type II CRISPR–Cas system include the RNA-guided 
Cas9 endonuclease, originally characterised in multiple bacterial species such as Streptococcus 
pyogenes, a single guide RNA (sgRNA), and the trans-activating crRNA (tracrRNA) [22,23]. The 
sgRNA direct the Cas9 protein to the 20 nucleotide target sequence adjacent to a 5′-NGG-’3 
protospacer adjacent motif (PAM). Upon binding, the Cas9 endonuclease introduces a double 
strand break (DSB) in this target sequence. The DSBs can then be repaired by either an error-prone 
non-homologous end-joining (NHEJ) or the high-fidelity homology-directed repair (HDR) 
pathway. This approach has been applied for genome editing of mammalian cells [23], for genetic 
modification in animal models [24], and genomic manipulation of several DNA viruses such as 
herpes simplex virus type I, adenovirus, pseudorabies virus, vaccinia virus, Epstein–Barr virus, 
guinea pig cytomegalovirus, herpesvirus of turkey, and duck enteritis virus [25–32]. Accompanied 
by CRISPR/Cas9, the Cre–Lox recombination system can be applied to excise a pre-defined LoxP 
sites (34 base-pair DNA sequence) to cleave the DNA surrounded by LoxP sites [33]. 
In this study, we developed and applied a highly efficient, versatile, and rapid 
NHEJ-CRISPR/Cas9 and Cre–Lox-mediated genome-editing approach for simultaneous deletion of 
pre-determined virulence factors and insertion of viral antigen to generate recombinant, 
multivalent, and safer vaccine vectors. We demonstrated the use of this approach first by the 
generation of a reporter virus and deletion of TK gene from ILTV genome. Thereafter, we 
engineered an ILTV-vectored vaccine candidate harbouring fusion gene (F) of the velogenic NDV 
and deletion of another gene, US4, from the ILTV genome. The reporter marker gene was excised 
using Cre–Lox system without affecting the expression and stability of the F protein. This potential 
vaccine candidate was assessed for the stable expression of inserted protein, replication kinetics, 
and for comparative in vitro characteristics. We demonstrate that NHEJ-CRISPR/Cas9 accompanied 
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by Cre–Lox is an efficient method for rapid generation of ILTV-based recombinant vaccines and 
proposes multiple advantages to traditional recombination and recombineering techniques 
2. Materials and Methods  
2.1. Cell Culture and Viruses 
Leghorn male hepatoma (LMH) cells, kindly provided by Prof Venugopal Nair, The Pirbright 
Institute UK, were maintained in Dulbecco’s Modified Eagle Medium (DMEM; Sigma) 
supplemented with 10% foetal bovine serum GlutaMAX and penicillin–streptomycin (100 U/ml, all 
from Thermo Fischer Scientific). Gallid alphaherpesvirus 1 strain was obtained from American Type 
Culture Collection. 
2.2. Construction of sgRNAs and Donor Plasmids 
The gRNA targeting the UL47/US4 intergenic region and downstream of US4 gene in ILTV 
genome was designed using online CRISPR guide RNA designing software (http://crispr.mit.edu/). 
Synthesised oligonucleotide pairs were annealed and cloned into BbsI restriction sites of pX459-v2 
CRISPR/Cas9 vector (Addgene #62988). For the construction of green fluorescent protein (GFP) 
donor cassette, the GFP was flanked upstream with pEFa promoter and downstream with the 
polyA tail. Synthetic oligos carrying sgA target sites were cloned on 5′ and 3′ ends of this cassette 
(Table S1). For the construction of the dsRED carrying donor plasmid (pCDNA3-CRISPR-Lox-wt), a 
synthesised oligo containing two multiple cloning sites, a pair of LoxP sites, and two guide RNA 
targeting sequences (SgA and SgB) were digested with BsmBI and cloned into pCDNA3 vector via 
BbsI and MfeI restriction sites. The dsRED gene was amplified from pCDNA3-dsRED vector and 
cloned into MCS2 of donor backbone with the use of EcoRI and XbaI enzymes, generating 
pCDNA3-CRISPR-Lox-MCS2dsRED. Finally, the F gene of NDV was amplified from genotype VII 
strain of Egyptian origin with FClon1F/R primers set and cloned into MCS1 site by NheI and KpnI 
double digestion to generate pCDNA3-CRISPR-Lox-MCS1F-MCS2dsRED. 
2.3. Generation of Recombinant ILTV 
LMH cells were seeded in 6-well plates and a total of 1 µg of plasmid expressing each of the 
gRNAs, along with 1 µg donor plasmid, were co-transfected into LMH cells using Lipofectamine 
2000 (Thermo-Fischer Scientific) according to the manufacturers’ instructions. At 24 h 
post-transfection, ILTV was infected into the LMH cells at 0.01 multiplicity of infection (MOI). Cells 
were incubated until plaques progressively appeared for GFP or both GFP and dsRED signals. 
Those plaques were then picked and passaged several times in LMH cells and confirmed by PCR.  
Cre–Lox system was used to excise dsRED from recombinant virus backbone. Briefly, 6-well 
plates including LMH cells were transfected with 2 µg of the pCAG-Cre (Addgene #13775). After 24 
h post-transfection, cells were infected with 100 plague-forming units of ΔTK&ΔUS4-dsRED+ve 
ILTV. Cells were again incubated until only GFP appeared in cells. These plagues were then picked 
and confirmed by PCR and confocal microscopy. 
2.4. Characterisation of Recombinant ILTV Viruses 
LMH cells were plated in 6-well plates for 24 h before infection with purified ΔTK-GFP+ ILTV, 
ΔTK&ΔUS4-dsRED+ve ILTV, ΔTK&ΔUS4-Cre ILTV or wild type (wt) ILTV the following day. The 
infected cells were harvested after 72 h of infection and subjected for DNA extraction using a 
DNeasy Blood & Tissue Kit (Qiagen). PCR targeting the F gene was carried out using specific 
primers, shown in Table S1, for identification of the recombinant ΔTK&ΔUS4-dsRED+ve ILTV 
compared to ILTV wild-type and ΔTK-GFP+ ILTV. The PCR products were purified using a 
GenElute Gel Extraction Kit (Sigma Aldrich, Germany) and sequenced using the primers listed in 
Table S1 to confirm the insertion of the F gene. 
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2.5. Western Blot Analysis 
Expression of the F protein in recombinant virus-infected LMH cells was determined by 
Western blot analysis using anti-F monoclonal antibody (Mab) [34] as the primary antibody. After 
48–72 hours post-infection with recombinant viruses, cells were washed one time with ice-cold 
phosphate buffered saline (PBS). Lysis for the infected cells was carried out by adding 100 µL 
ice-cold NP40 buffer (completed with protease inhibitors cocktail) per well for 30 min on ice. Cells 
were scrapped off and transferred to 1.5 mL microfuge tube. Using 25 G needle X6, the lysate was 
passed through the up and down to ensure complete disruption of cells. The lysis was then left on 
ice for 15 min, followed by centrifugation at 13,000 rpm for 5 min at 4 °C. The lysates (supernatant) 
of infected cells were incubated in sample buffer containing 10% β-mercaptoethanol for 5 min at 98 
°C, and separated on a 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
(SDS-PAGE), and the resolved proteins were transferred onto polyvinylidene difluoride (PVDF) 
membranes. Immunoblots were blocked with 5% skimmed milk, and then incubated with primary 
antibodies (1:100 dilution). After probing with primary antibodies, the blots were incubated with 
peroxidase-conjugated species-specific secondary antibodies and visualised by chemiluminescence 
(Chemidoc, BioRad, USA). 
2.6. Indirect Immunofluorescence Analysis 
The expression of the F protein in recombinant virus-infected cells was evaluated by 
immunofluorescence assays using confocal microscopy. LMH cells, grown on coverslips in 24-well 
plates, were infected with the recombinant viruses for 48–72 h before harvesting. After fixing the 
cells with 4% paraformaldehyde and permeabilisation with 0.1% Triton X-100, cells were incubated 
with primary antibodies raised against NDV [34]. Afterwards, cells were incubated with 
corresponding secondary antibodies for 2 h. The F protein expression was analysed through 
fluorescence for wild-type and recombinant ILTV. Cell nuclei were then stained with 
40,6-diamidino-2-phenylindole (DAPI), and the images were taken using a Zeiss confocal 
laser-scanning microscope (Zeiss, Germany). 
2.7. Stability of the Inserted Genes in the Recombinant ILT Viruses 
The recombinant viruses were grown sequentially in LMH cells for at least 15 passages. The 
integrity of the F gene was examined by PCR (with primer pairs FusClon1 and FusClon2 which 
amplifies the full-length F gene) using DNA extracted from different passages. 
2.8. In Vitro Growth Kinetics and Plague Assay 
To investigate the growth properties of the recombinant ILTV, LMH cells in were infected in 
6-well plates with 100 pfu of each virus (wild-type ILTV, ΔTK-GFP+ ILTV, and 
ΔTK&ΔUS4-dsRED+ve ILTV) and harvested at 0, 4, 8, 12, 24, 48, and 72 h post-infection to 
determine the in vitro growth kinetics using the methods described previously [35]. DNA was 
extracted using a DNeasy Blood & Tissue Kit (Qiagen) and used for real-time qPCR. Real-time 
qPCR was carried out to detect ILTV gB gene [36], which enabled the calculation of ILTV genome 
copies that was plotted against hours post-infection for each of the viruses to produce standard 
curves. 
LMH cells were infected at MOI of 0.2, and the growth kinetics were assayed as described 
[37,38]. Progeny virus plaques were visualised by IFA using an NDV F-specific MAb [34] or 
fluorescence for ΔTK-GFP+ ILTV and ΔTK&ΔUS4-dsRED+ve ILTV. At different time points after 
infection, cells and supernatants were harvested and lysed by freeze–thawing and the mean 
progeny titres for each time point after infection were calculated. Furthermore, 30 plaques per virus 
mutant were measured microscopically, and average diameters as well as standard deviations were 
calculated. 
2.9. Statistical Analyses 
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Pairwise comparisons of virus-treated and control groups were performed using Student’s 
t-test. All statistical analyses and figures were conducted in the GraphPad Prism (GraphPad 
Software, La Jolla, CA, USA). 
3. Results 
3.1. Targeted Deletion of TK Gene and Simultaneous Knock-In of GFP Expression Cassette into the ILTV 
Genome Using NHEJ-CRISPR/Cas9 Approach 
The thymidine kinase (TK) is one of the most virulent factors in ILTV pathogenesis, and it has 
been previously reported that deletion of TK from the ILTV genome attenuates the virus without 
compromising the replication and immunogenicity [39]. To demonstrate the genome editing 
approach for ILTV, we first aimed to delete the TK gene by CRISPR–Cas9 excision using 
target-specific sgRNA at both up- and downstream regions of the TK gene (Table S1). In order to 
exclude any possible deleterious effects of this deletion on the virus replication, and to 
simultaneously generate a marker virus, a reporter donor plasmid was constructed. This plasmid 
carried GFP reporter gene cassette comprised of eukaryotic translation elongation factor alpha 1 
(pEFα) promoter, gene encoding GFP and corresponding polyA tail. The entire cassette was flanked 
with sgRNA-targeted sites to cleave the GFP expression fragment in vitro (Figure 1A). Two sgRNA 
(sgA) corresponding the targeting sites in the donor plasmid to release expression fragment and 
two sgRNA targeting the viral genome surrounding the TK gene were cloned into pX459v2, which 
expresses sgRNA by the U6 promoter and bicistronically expresses the human codon optimised 
Streptococcus pyogenes Cas9 through cytomegalovirus (CMV) promoter. Cleavage of the viral 
genome by Cas9 and concurrent excision of expression cassette from the donor plasmid DNA will 
simultaneously delete the TK gene and introduce the GFP, as outlined in Figure 1A. 
The NHEJ is a superior pathway over HDR and has been demonstrated by several studies in 
eukaryotic cells [28], animals [24], and DNA viruses [31]. Therefore, we used NHEJ mechanisms to 
knock-in the expression cassettes into the viral genome. To demonstrate this process for the ILTV, 
the CRISPR/Cas9 system, including donor plasmid, sgRNAs targeting ILTV genome, and sgRNAs 
cleaving the donor plasmid, were transfected in LMH cells for 24 h and were infected with 
multiplicity of infection (MOI, 1.0) of wild-type ILTV. These transfected and subsequently infected 
cells were passaged after every 3 days until GFP plagues were observed (Figure 1B). These progeny 
virus plaques carrying the knock-in cassette of GFP and deleted TK genes were individually picked, 
propagated, and designated as ΔTK-GFP+ ILTV. 
In order to confirm the insertion of the GFP in the TK locus, we amplified the TK gene-flanking 
region using site-specific primers (Table S1). Compared to the wild-type ILTV, the ΔTK-GFP+ ILTV 
showed an insert of GFP (Figure 1C). However, this insertion could be due to DSB by a single 
gRNA instead of TK excision. To exclude this possibility, we sequenced the amplified PCR products 
and observed an excision of intentional TK gene and insertion of the GFP reporter gene, 
highlighting the occurrence of InDel events and error-prone NHEJ-mediated DNA repair 
mechanism. 
Next, we demonstrated the replication kinetics of ΔTK-GFP+ ILTV and showed that ΔTK-GFP+ 
ILTV replicated competitively and progressively (Figure 1D) over a period of 2 days. The purified 
virus was passaged for more than 25 times without the repulsion of the marker GFP, demonstrating 
the stability of the insert (see below). These data validate the proposed approach on simultaneous 
deletion and insertion of genes in the ILTV genome and potential for the development of safer and 
stable vaccine candidates. 
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Figure 1. Homology-independent knocking-out of TK gene and knocking-in of a reporter gene into 
the infectious laryngotracheitis virus (ILTV) genome using CRISPR/Cas9-induced and 
non-homologous end-joining (NHEJ)-mediated double stranded DNA break and repair 
mechanisms. (A) Schematic diagram outlining the genomic organisation of the ILTV genome. The 
internal and terminal repeat short (IRS/TRS) and unique long (UL) and short (US) regions of the 
ILTV genome are shown. Important viral genes and their orientations are labelled at the bottom and 
approximate scale of the genome size is displayed at the top of the viral annotated genome. The 
schematic illustration of the donor plasmid and targeting strategy for CRISPR/Cas9-induced and 
NHEJ-mediated insertion of green fluorescent protein (GFP) reporter gene, which replaces the TK 
gene in the ILTV genome. The upstream promoter, downstream polyA tail, and sgRNA sites 
flanking the expression cassette are shown. (B) The leghorn male hepatoma (LMH) cells were 
transfected with plasmid carrying donor reporter cassette, expressing sg-A and Cas9 for 24 h and 
infection with ILTV until appearance of foci. Immunofluorescence visualisation of the ILTV plagues 
expressing GFP cassette (upper panel) and wild type (wt) ILTV control (lower panel). (C) LMH cells 
were infected with ΔTK-GFP+ ILTV, wild-type ILTV, or left uninfected for 48 h before extraction of 
the total DNA for PCR analysis. (D) LMH cells were infected with ΔTK-GFP+ ILTV and wt ILTV, 
and the expression of the GFP was visualised using fluorescence microscopy at different time points 
for 2 days. 
3.2. Deletion of US4 and Targeted Knock-In of Fusion Gene of NDV and dsRED Expression Cassettes into 
the ΔTK-GFP+ILTV Genome 
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After successful demonstration that marker genes could be inserted in the target site of the 
ILTV genome and the corresponding genes can be deleted from the backbone of ILTV by 
CRISPR/Cas9 technology, we aimed to construct a recombinant bivalent vaccine against NDV and 
ILTV. To further facilitate the efficient and rapid development of recombinant vaccines, we 
generated a universal and versatile donor system, which can be exploited to develop vaccine 
independent of pathogen or host sequences. The entire cassette consisting of expression of two 
individual genes by independent promoters was generated (Figure 2A, inset). The dsRED 
expression cassette was then flanked with LoxP sites to facilitate the excision of the marker gene by 
the Cre-recombinase (Figure 2A). Additionally, the full-length cassette and the antigen (F gene of 
NDV in this case) expression cassette were flanked with the sgA or sgB for in vitro swapping of 
corresponding genes, respectively. 
In addition to TK deletion, we aimed to delete US4, which is a known immune modulator in 
ILTV infection, to further enhance the safety profile of the ILTV vaccine vectors. A total of three 
pairs of sgRNA targeting variable regions in and around the US4 gene were cloned into the 
pX459v2, which expresses sgRNA via U6 promoter and Cas9 by the CMV promoter (Table S1). 
The LMH cells were co-transfected with donor plasmid, as well as with Cas9/gRNA vectors 
targeting US4 and donor vector cleavage sites for 24 h, and then were infected with ΔTK-GFP+ 
ILTV. These transfected/infected cells were passaged until dsRED plaques appeared and 
overlapped with the GFP plaques (Figure 2B). The progeny virus plaques expressing dsRED were 
isolated, plague purified and termed as ΔTK&ΔUS4-dsRED+ ILTV. In order to demonstrate the 
insertion of the entire cassette, the plague purified viruses were used to extract total genomic DNA 
and used to amplify the cassette using flanking 5′ and 3′ specific primers (Table S1). The product 
size and sequencing of the fragments showed the deletion of US4 and insertion of the entire cassette 
of ~5kb in size (Figure 2C). We also demonstrated that insertion of the expression cassette did not 
show prominent impacts on the replication kinetics of the ΔTK&ΔUS4-dsRED+ ILTV determined by 
the sequential fluorescent microscopy (Figure 2D) and qPCR targeting gB gene of the ILTV. 
Moreover, recombinant and wt ILTVs showed marked replication, as shown by plaque assays in 
LMH cell line (Figure 4). 
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Figure 2. Homology-independent knock-out of US4 and knock-in of the F gene of Newcastle disease 
virus (NDV) into the ILTV genome using CRISPR/Cas9. (A) Schema of the ILTV and strategy for the 
construction of donor plasmid. The insertion cassette is shown in the inset. Two multiple cloning 
sites (MCS) were flanked upstream with the promoter and downstream with the corresponding 
polyA tail. Full length F gene of the NDV was cloned in the MCS1 site whereas dsRED was cloned 
in the MCS2 site. The dsRED cassette was flanked with the LoxP sites at the 5′ and 3′ ends to be 
excised by Cre-recombinase. The entire cassette was flanked with sgA/sgB target site to release the 
cassette by the Cas9 and was cloned between BsmB1 sites in the pcDNA3.1. The donor plasmid and 
plasmids expressing sgRNA targeting the entire length of the US4 and cassette, as well as Cas9 
expression plasmids, were co-transfected in LMH cells for 24 h before infection with ΔTK-GFP+ 
ILTV. (B) The plagues co-expressing the GFP (representing ΔTK-GFP+ ILTV) and dsRED 
(representing ΔTK&ΔUS4-dsRED+ve ILTV) were visualised by confocal microscopy. (C) LMH cells, 
infected with ΔTK-GFP+ ILTV, ΔTK&ΔUS4-dsRED+ve ILTV, and wt ILTV viruses, were collected 
for PCR analysis. (D) LMH cells were infected with ΔTK&ΔUS4-dsRED+ve ILTV, and the 
expression of the GFP and dsRED was visualised using fluorescence microscopy at different time 
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3.3. Excision of the dsRED from Knocked-In Expression Cassette from the ΔTK&ΔUS4-dsRED+ ILTV 
Genome Using Cre–Lox Recombinase 
 
Figure 3. Excision of dsRED from the ΔTK&ΔUS4-dsRED+ve ILTV using Cre–Lox system. (A) 
Genomic organisation of the ILTV and strategy for the Cre-recombinase-mediated excision of the 
dsRED through LoxP sites. (B) LMH cells were transfected with Cre-recombinase expressing 
plasmid or mock transfected for 24 h and were then infected with ΔTK&ΔUS4-dsRED+ve ILTV for 
72 h. The excision of the dsRED was observed using fluorescence microscopy. Bright field, and 
dsRED and GFP-positive fields were presented. (C) LMH cells infected with wt ILTV, ΔTK-GFP+ 
ILTV, ΔTK&ΔUS4-dsRED+ve ILTV, and ΔTK&ΔUS4-Cre-ILTV viruses were collected for PCR 
analysis. Note the absence of dsRED in ΔTK&ΔUS4-Cre-ILTV-infected cells. (D) LHM cells were 
infected with ΔTK&ΔUS4-Cre-ILTV and stained for the F protein of NDV. (E) LMH cells were 
infected with ΔTK&ΔUS4-Cre-ILTV, and the expression of the GFP was visualised using 
fluorescence microscopy at different time points for 3 days. 
M Munir  5/12/2019 10:45
Deleted: Dsred 
M Munir  5/12/2019 10:45
Deleted: δTk
M Munir  5/12/2019 10:46
Deleted: δ
M Munir  5/12/2019 10:51
Deleted: us
M Munir  5/12/2019 10:45
Deleted: Dsred
M Munir  5/12/2019 10:45
Deleted: Iltv 
Vaccines 2019, 7, x 10 of 15 
 
In order to delete the dsRED from ΔTK&ΔUS4-dsRED+ ILTV, LHM cells were transfected with 
Cre-recombinase expressing pcDNA3-Cre plasmid (Addgene#13775) for a day before infection with 
the recombinant virus (Figure 3A). Cells expressing GFP only where dsRED was excised by the 
recombinase (dsRED negative) were selected, purified, propagated, and designated as 
ΔTK&ΔUS4-Cre ILTV (Figure 3B). The deletion of dsRED was further confirmed in the purified 
recombinant virus by PCR primers specifically targeting the dsRED (Table S1). As expected, the 
dsRED expression cassette was only detected in the ΔTK&ΔUS4-dsRED+ ILTV, whereas the 
ΔTK&ΔUS4-Cre ILTV lacked the dsRED cassette (Figure 3C). Immunostaining of the F protein of 
NDV in ΔTK&ΔUS4-Cre-infected LMH cells showed an intact expression of transgene even after 
dsRED excision (Figure 3D). The dsRED-deleted ILTV replicated competitively compared to the 
ΔTK&ΔUS4-dsRED+ ILTV, as was observed in the time course fluorescence microscopy (Figure 3E), 
qPCR, and plaque assay (Figure 4). These results demonstrate that Cre–Lox system offers a 
convenient tool to eliminate the expression of selection genes, without affecting the expression of 
spared genes and virus replication. 
3.4. Stable Expression of Fusion Protein of NDV in Recombinant ILTV 
Having demonstrated that CRISPR/Cas9 and Cre–Lox system is an effective, convenient and 
fast approach to generate recombinant vaccine candidates and to generate potential attenuated 
strains, we next investigated if the inserted F gene of NDV could be expressed in recombinant 
ILTVs. For this purpose, LMH cells were either mock-treated or infected with wt ILTV, ΔTK-GFP+ 
ILTV or ΔTK&ΔUS4-dsRED+ ILTV, and the lysate was use for the expression of the F protein. The 
expression was assessed by Western blotting using antibodies against the F protein of the NDV 
whereas antibodies targeting alpha tubulin were used as loading control. As anticipated, cell lysate 
from ΔTK&ΔUS4-dsRED+ ILTV-infected cells demonstrated expression of the F protein (Figure 4A, 
Figure S1) and it was absent in the wt ILTV and ΔTK-GFP+ infected cell lysates. 
We next assessed whether Cre–Lox mediated excision adversely impacted the inserted genes. 
Western blotting of the cells lysate, prepared from LMH cells which were infected with 
ΔTK&ΔUS4-dsRED+ ILTV as well as ΔTK&ΔUS4-Cre ILTV, showed expected expression of F 
protein and no corresponding expression was observed in cells which were infected with parental 
ILTV or recombinant ILTV lacking genes for F proteins of NDV (Figure 4B, Figure S1). These results 
demonstrate that Cre–Lox system can safely excise gene without negatively impacting the 
expression of associated proteins. 
3.5. In Vitro Replication and Stability of Recombinant ILTVs 
After assessing the successful expression of the F protein, we aimed to determine whether the 
insertion of the cassette influences the replication kinetics of the recombinant ILTVs. To this end, 
LMH cells were infected with parental and recombinant ILTV viruses and the virus replication 
rates were assessed using qPCR and fluorescent microscopy. Analysis of the genomic replication 
and viral replication progression (Figure 4C) did not show significant differences between 
recombinant ILTVs generated in this study and wild-type ILTVs. 
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Figure 4. Characterisation of the recombinant ILTVs generated using CRISPR/Cas9 and Cre–Lox 
system. (A) LMH cells were infected with wt ILTV, ΔTK-GFP+ ILTV, or ΔTK&ΔUS4-dsRED+ve 
ILTV (all passaged at least 15 times) or left uninfected for 48 h. Cells were lysed and expression of 
the F protein of NDV was determined using Western blotting, and alpha tubulin was used as 
loading control. (B) LMH cells were infected with wt ILTV, ΔTK-GFP+ ILTV, 
ΔTK&ΔUS4-dsRED+ve ILTV, ΔTK&ΔUS4-Cre-ILTV, or left uninfected for 48 h. Cells were lysed 
and expression of the F protein of NDV was determined using Western blotting, and alpha tubulin 
was used as loading control. (C) In vitro growth kinetics were performed using real-time PCR on 
DNA extracted from LMH cells at various time points post-infection with wt ILTV, ΔTK-GFP+ 
ILTV, ΔTK&ΔUS4-dsRED+ve ILTV, ΔTK&ΔUS4-Cre-ILTV, or from uninfected cells. (D) PCR was 
applied to confirm the stability of F gene expression cassette from the recombinant viruses at 
passage 1, 3, 5, 7, 10, and 15 in LMH cells using primers targeting the F gene. (E) LMH cells were left 
uninfected or infected with wt ILTV, ΔTK-GFP+ ILTV, ΔTK&ΔUS4-dsRED+ve ILTV, or 
ΔTK&ΔUS4-Cre-ILTV for 2 h and were covered with overlay media for 10 days before staining with 
crystal violet and measuring for plaque sizes. 
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In order to estimate the stability of the expression cassette, recombinant ILTV generated by 
genome editing were passaged for at least 15 times in LMH cells, and the stability of the inserted 
cassette was assessed using F gene specific PCR. Continuous assessment of the F gene cassette 
showed no apparent loss or reduction in the F gene products indicating a stable integration of the 
cassette in the ILTV genome (Figure 4D). Additionally, we infected the LMH cells with recombinant 
and parental ILTVs (passaged for at least 15 times) and measured the sizes of plagues. All viruses 
(recombinants and parental) showed insignificant variations in plagues sizes (Figure 4E). 
Taken together, these data demonstrate that transgene insertion in the ILTV genome using 
CRISPR/Cas9 and excision of genes with Cre–Lox is a reliable approach to stably express genes. 
4. Discussion 
The ILTV vectors carry remarkable capacity to express heterologous antigens, and are 
consistently being applied in the poultry industry for immunisation against multiple viruses, 
including NDV, and influenza H5 and H7 strains [15–17]. With these proven applications of ILTV, 
the generation of recombinant viruses to expression foreign genes has been achieved using 
conventional recombination strategies, which are tedious, time-consuming, and error prone [18]. 
We have demonstrated here the feasibility of the CRISPR/Cas9 nucleases accompanied by the Cre–
Lox recombinase in constructing a recombinant ILTV vector expressing either surface antigen of 
NDV or marker proteins (GFP and dsRED). 
While ILTV proposes satisfactory induction of cellular and humoral immunity, and conferring 
protection against multiple strains of ILTV, latency, and reactivation are crucial for the permanence 
of ILTV in the poultry field. The molecular mechanisms in establishment and reactivation of ILTV 
latency are not fully understood. However, it has been proposed that the intimate viral–host 
interactions and the immune surveillance during latent infections are decisive factors [18]. 
Therefore, several previous studies have been conducted to delete virulence-determining gene such 
as dUTPase, thymidine kinase [10], secreted glycoprotein gG [35], tegument protein pUL47 [39], or 
iltovirus-specific pUL0 [7]. These gene-deleted ILTV mutants showed attenuation in vivo. However, 
these studies have only focused on the deletion of individual genes and thus limit its safety, and 
necessitating deletion of multiple non-essential genes to propose a better, safer and 
immune-competent vaccine vector. 
This is the first study to demonstrate the application of CRISPR/Cas9 system in the 
development of recombinant ILTV vaccines. The presented pipeline proposes a straightforward, 
rapid, and efficient approach to develop ILTV-based novel recombinant vaccines to protect against 
major diseases of the poultry. Compared to traditional technologies for modification, the Cas9 
endonuclease generates guided and targeted double stranded breaks, which are then repaired by 
either of the two cellular repair mechanisms; NHEJ or HDR [40,41]. In contrast to the HDR 
pathway, which occurs in the S and G2 phases of cell division, NHEJ is efficient and occurs 
throughout the cell division cycle [42]. Using single bait, red fluorescent protein (RFP) has been 
knocked-in to the pseudorabies virus with high efficacy through the NHEJ pathway [28]; however, 
this may lead to undesirable, error-prone, and unpredictable insertions. To mitigate this 
complication, we introduced dual-baits at the 5′ and 3′ ends of the insert. Since the bait sequence is 
independent of the sequence of the targeted virus and host, and is devoid of specific sgRNA 
selection, our benefactor system proposes a universal donor, which would be a valuable source for 
generation of multivalent vaccines against poultry pathogens. 
As a proof of principle, we applied this approach to first generate a reporter ILTV by 
successfully and efficiently knocking-in a GFP expression cassette. In addition, we diversified the 
system by instantaneously deleting the virulence factors from the ILTV as a dynamic approach to 
concurrently attenuate the virus and to generate a marker virus. Using existing information on the 
roles of TK in ILTV attenuation [10], the generated ΔTK-GFP+ ILTV replicated competitively and 
sustainability. While individual genes have been deleted from ILTV genome, no studies have been 
performed to delete multiple genes from the same ILTV strain, which may propose a better and 
safer solution to the immunisation in poultry. 
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To follow up this line of safety, we generated a universal and repair donor vector system with 
a feature to efficiently excise dsRED marker flanked with LoxP sites and unique restriction sites to 
insert and swap heterologous genes of interest. We next applied our validated CRISPR/Cas9 
approach to insert the entire cassette of ~5kb into the ILTV genome using gRNA flanking the US4 
virulence factor. The pipeline showed an efficient and rapid production of recombinant ILTV 
vaccine expressing heterologous antigen, fusion gene of NDV, and excisable dsRED. After 
successful rescue of the virus, in vitro characterisation and stability studies, the dsRED was deleted 
using Cre-recombinase enzyme. Insertion of the F gene expression cassette was stable and did not 
compromise the replication of ILTV, as was monitored until at least 15 passages in vitro. However, 
potential implications of inserted genes on the replication of recombinant ILTV “in vivo” and as 
“vaccine candidate” warrant further research. Moreover, this double genes-deleted recombinant 
ILTV will act as marker vaccine permitting differentiation of successfully immunised from infected 
chickens (DIVA). To facilitate the detection of TK-specific serum antibodies, competitive diagnostic 
assays can be devised utilising TK expression constructs and TK-specific monoclonal antibodies. 
Taken together, we described a versatile and customisable pipeline for the development of 
NHEJ-CRISPR/Cas9 and Cre–Lox system in the development of innovative ILTV-vectored vaccines. 
While the approach has displayed the expression of the F protein of the NDV, it is feasible to 
develop future ILTV-vectored vaccines by insertion of multiple viral antigens at locations different 
than applied here. We have screened and identified additional sites, which appear safe and can 
accommodate longer genes without compromising the ILTV replication (Atasoy et al., unpublished 
data). Additionally, the same platform can be applied to engineer other avian DNA viruses to 
develop new multivalent-vectored vaccines for protecting multiple poultry diseases. 
Conclusions 
In summary, the application of CRISPR/Cas9 genome editing and Cre–Lox platforms are 
effective means to deploy new multivalent-vectored vaccines, which can be stepping stones to 
contain poultry infections, especially in disease-endemic countries where multiple pathogens 
circulate and pose devastating disease outcomes. 
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